Tag: Competition

Displaying 121 - 140 of 1910 results.

Global pharmaceutical company Novartis AG has agreed to divest all assets related to its BRAF and MEK inhibitor drugs, currently in development, to Boulder, Colorado-based Array BioPharma to settle charges that Novartis’s $16 billion acquisition of GlaxoSmithKline’s portfolio of cancer-treatment...
As anyone of a certain age can attest, the 1970’s were all about change. Hairstyles and hemlines were obvious signs, but in the world of antitrust, change came in the form of applying competition standards to the “learned professions,” and new thinking about the role of competition...
Agency Charges Merger Would Create a National Broadline Foodservice Distributor With 75 Percent Market Share, and Harm Customers in Numerous Local Markets
Reminder: your appointment is coming up soon! Staff of the Federal Trade Commission and the U.S. Department of Justice Antitrust Division just posted the agenda for next week’s two-day health care workshop. One look, and you won’t need a second opinion – you definitely will want to...
The Federal Trade Commission and the U.S. Department of Justice’s Antitrust Division have issued an agenda and posted speaker bios for their joint workshop in the series Examining Health Care Competition. The workshop will take place on February 24-25, 2015, in the Constitution Center Auditorium...
Following a public comment period, the Federal Trade Commission has approved an application for prior approval from Merck & Co., Inc. to sell its Barcelonata facility to Merial Barceloneta LLC, a subsidiary of Merial Inc. Merck currently contract-manufactures the canine heartworm medications...
The Ninth Circuit today affirmed the district court’s ruling that the merger of St. Luke’s Health Systems, Ltd. and Saltzer Medical Group violated Section 7 of the Clayton Act. Nearly two years ago, the Commission and the State of Idaho filed a complaint in federal court alleging...
The decision affirms the decision by the U.S. District Court in the District of Idaho, which held that the acquisition violated Section 7 of the Clayton Act and the Idaho Competition Act, and ordered St. Luke’s to fully divest itself of Saltzer’s physicians and assets.
From: Walsh, Kathryn E.Sent: Wednesday, January 28, 2015 9:42 AMTo: (Redacted)Cc: (Redacted), Subject: Berg, Karen E.; Gillis, Diana L.RE: HSR/size of person question(Redacted) - the PNO position is that once assets are listed on the balance sheet, there is little flexibility in the...
From: Gillis, Diana L. Sent: Friday, January 30, 2015 3:27 PM To: (Redacted) Cc: Walsh, Kathryn E.; Pope, Susan H.; Whitehead, Nora Subject: RE: 802.9 Quick Question We think being a director of target and officer of the PE firm that will be the GP of buyer precludes using the...
From: Walsh, Kathryn E. Sent: Friday, January 30, 2015 2:27 PM To: (Redacted) Cc: Gillis, Diana L.; (Redacted); Whitehead, Nora Subject: RE: HSR Valuation Question (Redacted), as we just discussed, Diana and I think you have to include the borrowed funds because Newco is a...
From: Pope, Susan H. Sent: Thursday, January 15, 2015 1:02 PM To: (Redacted) Cc: (Redacted), Walsh, Kathryn E.; Gillis, Diana l. Subject: FW: Item 5 Revenues for Insurance Operations Attachments: RE: Item 5 Revenue Reporting Confirmation (Redacted), Confirming our previous...
From: Verne, B. Michael Sent: Monday, December 29, 2014 2:23PM To: (Redacted) Cc: (Redacted), Walsh, Kathryn E. Subject: FW: Request for Guidance on Applicability of 15 USC 18a(c)(1) and 16 CFR 802.1 [ED-Ol.FID3414100] Subject: RE: Request for Guidance on Applicability of 15 USC...
From: Walsh, Kathryn E.Sent: Tuesday, December 30, 2014 3:10 PMTo: (Redacted)Subject: RE: quick queryRight. From: (Redacted)Sent: Tuesday, December 30, 2014 3:09PMTo: Walsh, Kathryn E.Subject: RE: quick queryThanks, Kate. Since it acts like an LP, does that mean that we would not...
From: Walsh, Kathryn E.Sent: Thursday, January 08, 2015 1:40 PMTo: (Redacted)Cc: Gillis, Diana L.; Pope, Susan H.; Whitehead, NoraSubject: RE: Request for informal interpretation(Redacted) - we agree with your take. From: (Redacted)Sent: Thursday, January 08, 2015 12:42 PMTo: Walsh,...
From: Verne, B. Michael Sent: Wednesday, December 03, 2014 1:03PM To: (Redacted); Walsh, Kathryn E. Cc: (Redacted) Subject: RE: HSR Question-- Pharma License
From: Verne, B. Michael Sent: Wednesday, December 03, 2014 3:01PM To: (Redacted) Cc: Walsh, Kathryn E. Subject: RE: 802.64- Finance Company (Redacted) - looking back to the SBP for the 1978 Final Rule 802.64, it appears that the type of entity you are describing was specifically...

Pages